This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xia, W. Articles by Gelman, I. H. Search for Related Content PubMed PubMed Citation Articles by Xia, W. Articles by Gelman, I. H.

The Src-suppressed C Kinase Substrate, SSeCKS, Is a Potential Metastasis Inhibitor in Prostate Cancer¹

Departments of Microbiology [W. X.], Pathology [P. U.], Clinical Immunology [L. M.], and Medicine [I. H. G.], Mount Sinai School of Medicine, New York, New York, 10029-6574, and Department of Urology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 [J. N.]

The molecular mechanisms leading to prostate cancer remain poorly understood, especially concerning the progression to the metastatic form. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, is likely the rodent orthologue of human Gravin/AKAP12, a scaffolding protein for protein kinases A and C. Gravin was mapped as a single-copy gene to 6q24–25.2, a hotspot for deletion in advanced prostate cancer, and therefore, we investigated the role of SSeCKS/Gravin in prostate oncogenesis. SSeCKS/Gravin protein was detected in untransformed rat and human prostate epithelial cell lines EP12 and PZ-HPV-7, respectively, and in human prostatic epithelium, especially basal epithelial cells. In contrast, SSeCKS/Gravin protein and RNA levels were severely reduced in human (PC-3, PPC-1, LNCaP, DU145, and TSU) and rat Dunning (AT3.1 and MatLyLu) prostate cancer cell lines. The regulated reexpression of SSeCKS in MatLyLu cells induced filopodia-like projections and a decrease in anchorage-independent growth. In nude mice, SSeCKS reexpression slightly decreased primary-site tumor growth but severely decreased the formation of lung metastases. Primary-site tumors that progressed lost regulated SSeCKS reexpression. SSeCKS/Gravin expression was detected in benign human prostatic lesions and well-differentiated carcinomas but not in undifferentiated lesions with Gleason sums 6. Our data suggest a role for the loss of SSeCKS/Gravin in the metastatic progression of human prostate cancer.

This article has been cited by other articles:

				B. Su, Y. Bu, D. Engelberg, and I. H. Gelman SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C- Raf/MEK/ERK Pathway J. Biol. Chem., February 12, 2010; 285(7): 4578 - 4586. [Abstract] [Full Text] [PDF]

				H. Z. Li, Y. Gao, X. L. Zhao, Y. X. Liu, B. C. Sun, J. Yang, and Z. Yao Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Breast Cancer Mol. Cancer Res., June 1, 2009; 7(6): 832 - 840. [Abstract] [Full Text] [PDF]

				M. Frontini, M. Vijayakumar, A. Garvin, and N. Clarke A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response Nucleic Acids Res., March 1, 2009; 37(4): 1073 - 1085. [Abstract] [Full Text] [PDF]

				Z. Jin, J. P. Hamilton, J. Yang, Y. Mori, A. Olaru, F. Sato, T. Ito, T. Kan, Y. Cheng, B. Paun, et al. Hypermethylation of the AKAP12 Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 111 - 117. [Abstract] [Full Text] [PDF]

				D. C. Weiser, U. J. Pyati, and D. Kimelman Gravin regulates mesodermal cell behavior changes required for axis elongation during zebrafish gastrulation Genes & Dev., June 15, 2007; 21(12): 1559 - 1571. [Abstract] [Full Text] [PDF]

				Y. K. Choi, J. H. Kim, W. J. Kim, H. Y. Lee, J. A. Park, S.-W. Lee, D.-K. Yoon, H. H. Kim, H. Chung, Y. S. Yu, et al. AKAP12 Regulates Human Blood-Retinal Barrier Formation by Downregulation of Hypoxia-Inducible Factor-1{alpha} J. Neurosci., April 18, 2007; 27(16): 4472 - 4481. [Abstract] [Full Text] [PDF]

				C. W. Rinker-Schaeffer, J. P. O'Keefe, D. R. Welch, and D. Theodorescu Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application. Clin. Cancer Res., July 1, 2006; 12(13): 3882 - 3889. [Full Text] [PDF]

				N Nathoo, A Chahlavi, G H Barnett, and S A Toms Pathobiology of brain metastases J. Clin. Pathol., March 1, 2005; 58(3): 237 - 242. [Abstract] [Full Text] [PDF]

				N. Sato, N. Maehara, and M. Goggins Gene Expression Profiling of Tumor-Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts Cancer Res., October 1, 2004; 64(19): 6950 - 6956. [Abstract] [Full Text] [PDF]

				P. S. Steeg PERSPECTIVES ON CLASSIC ARTICLES: Metastasis Suppressor Genes J Natl Cancer Inst, March 17, 2004; 96(6): E4 - E4. [Full Text]

				V.-M. Wasenius, S. Hemmer, E. Kettunen, S. Knuutila, K. Franssila, and H. Joensuu Hepatocyte Growth Factor Receptor, Matrix Metalloproteinase-11, Tissue Inhibitor of Metalloproteinase-1, and Fibronectin Are Up-Regulated in Papillary Thyroid Carcinoma: A cDNA and Tissue Microarray Study Clin. Cancer Res., January 1, 2003; 9(1): 68 - 75. [Abstract] [Full Text] [PDF]

				H. Kitamura, K. Okita, D. Fujikura, K. Mori, T. Iwanaga, and M. Saito Induction of Src-suppressed C Kinase Substrate (SSeCKS) in Vascular Endothelial Cells by Bacterial Lipopolysaccharide J. Histochem. Cytochem., February 1, 2002; 50(2): 245 - 256. [Abstract] [Full Text] [PDF]